The initial success of Viagra undeniably transformed the drug landscape, but placing funds in companies primarily reliant on unbranded versions presents a complex picture. Despite early returns were significant, the cessation of patents and the appearance of discounted alternatives have eroded the customer base. Therefore, a thorough analysis of pr